Design of the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis trial

Journal of Stroke and Cerebrovascular Diseases

Volumn 20, Issue 4, 2011, Pages 357-368

  Chimowitz, Marc I ^a   Lynn, Michael J ^b   Turan, Tanya N ^a   Fiorella, David ^c   Lane, Bethany F ^b   Janis, Scott ^d   Derdeyn, Colin P ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; intracranial; stenosis; stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGIOPLASTY; ARTICLE; BRAIN ARTERY; CEREBRAL REVASCULARIZATION; DIABETES MELLITUS; FOLLOW UP; HUMAN; LIFESTYLE MODIFICATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; STENOSIS; STENT; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

ANGIOPLASTY; ANTIHYPERTENSIVE AGENTS; ARTERIAL OCCLUSIVE DISEASES; ASPIRIN; CEREBRAL ARTERIAL DISEASES; CONSTRICTION, PATHOLOGIC; DRUG THERAPY, COMBINATION; HUMANS; HYPOLIPIDEMIC AGENTS; ISCHEMIC ATTACK, TRANSIENT; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SAMPLE SIZE; SECONDARY PREVENTION; STENTS; STROKE; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79959936182     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2011.05.001     Document Type: Article

References (40)

1. P. Gorelick, K. Wong, and H. Bae Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier Stroke 39 2008 2396 2399
2. J.F. Arenillas Intracranial atherosclerosis: Current concepts Stroke 42 1 Suppl 2011 S20 S23
3. L.K.S. Wong Global burden of intracranial atherosclerosis Int J Stroke 1 2006 158 159 (Pubitemid 44151508)
4. R. Wityk, D. Lehman, and M. Klag Race and sex differences in the distribution of cerebral atherosclerosis Stroke 27 1996 1974 1980 (Pubitemid 26372566)
5. R.L. Sacco, D. Kargman, and Q. Gu Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study Stroke 26 1995 14 20
6. M.I. Chimowitz, M.J. Lynn, and H. Howlett-Smith Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis N Engl J Med 352 2005 1305 1316
7. S. Kasner, M. Chimowitz, and M. Lynn Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis Circulation 113 2006 555 563
8. D.F. Fiorella, T.N. Turan, and C.P. Derdeyn Current status of the management of symptomatic intracranial atherosclerotic disease: The rationale for a randomized trial of medical therapy and intracranial stenting J NeuroIntervent Surg 1 2009 35 39
9. M.B. Rorick, F.T. Nichols, and R.J. Adams Transcranial Doppler correlation with angiography in detection of intracranial stenosis Stroke 25 1994 1931 1934 (Pubitemid 24291275)
10. E. Feldmann, J.L. Wilterdink, and A. Kosinski The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial Neurology 68 2007 2099 2106 (Pubitemid 46915385)
11. D.A. Katz, M.P. Marks, and S.A. Napel Circle of Willis: Evaluation with spiral CT angiography, MR angiography, and conventional angiography Radiology 195 1995 445 449
12. M.N. Nguyen-Huynh, M. Wintermark, and J. English How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke 39 2008 1184 1188 (Pubitemid 351440689)
13. O.B. Samuels, G.J. Joseph, and M.J. Lynn A standardized method for measuring intracranial arterial stenosis Am J Neuroradiol 21 2000 643 646 (Pubitemid 30210425)
14. P.M. Meyers, R.T. Higashida, and C.C. Phatouros Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries Neurosurgery 47 2000 335 343
15. American Diabetes Association Standards of medical care in diabetes - 2006 Diabetes Care 29 Suppl 1 2006 S4 42
16. S.M. Grundy, J.I. Cleeman, C.N.B. Merz for the coordinating Committee of the National Cholesterol Education Program (Endorsed by the National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, and American Heart Association) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239 (Pubitemid 38924592)
17. M.C. Fiore, W.C. Bailey, and S.J. Cohen Treating tobacco use and dependence. Quick reference guide for clinicians 2000 U.S. Department of Health and Human Services Rockville, MD
18. P. Poirier, T.D. Giles, G.A. Bray for the American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation 113 2006 898 918
19. T.N. Turan, M. Lynn, and M.I. Chimowitz Survey of US stroke neurologists and neurointerventionalists on treatment choices for intracranial stenosis Cerebrovasc Dis 23 Suppl 2 2007 131 [abstract]
20. D. Fiorella, E.I. Levy, and A.S. Turk US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results Stroke 38 2007 881 887 (Pubitemid 46568447)
21. O.O. Zaidat, R. Klucznik, and M.J. Alexander NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis Neurology 70 2008 1518 1524 (Pubitemid 351589505)
22. P.C. O'Brien, and T.R. Fleming A multiple testing procedure for clinical trials Biometrics 35 1979 549 556 (Pubitemid 10242750)
23. W.J. Jiang, X.T. Xu, and B. Du Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis Neurology 68 2007 420 426 (Pubitemid 46208744)
24. A. Bose, M. Hartmann, and H. Henkes A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: The Wingspan study Stroke 38 2007 1531 1537 (Pubitemid 46684170)
25. H.C. Diener, J. Bogousslavsky, and L.M. Brass MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial Lancet 364 2004 331 337
26. D.L. Bhatt, K.A.A. Fox, W. Hacke for the CHARISMA investigators Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
27. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
28. S. Chaturvedi, T.N. Turan, M.J. Lynn for the WASID Study Group Risk factor status and subsequent vascular events in patients with symptomatic intracranial stenosis Neurology 69 2007 2063 2068 (Pubitemid 350175708)
29. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 2006 549 559
30. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
31. B. Pitt, D. Waters, and W.V. Brown Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators N Engl J Med 341 1999 70 76 (Pubitemid 29314237)
32. W.E. Boden, R.A. O'Rourke, K.K. Teo COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
33. A.V. Chobanian, G.L. Bakris, H.R. Black National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
34. W.V. Brown, H.E. Bays, and H.A. Hassman Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomised, double-blind, 52-week trial Am Heart J 144 2002 1036 1043 (Pubitemid 36026917)
35. P.H. Jones, M.H. Davidson, E.A. Stein STELLAR Study Group Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) Am J Cardiol 92 2003 152 160 (Pubitemid 36835963)
36. T.A. Pearson, and T.D. Peters The treatment gap in coronary artery disease and heart failure: Community standards and the post-discharge patient Am J Cardiol 80 Suppl 8B 1997 45H 52H (Pubitemid 27515243)
37. G. Saposnik, S.G. Goodman, and L.A. Leiter Applying the evidence: Do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Stroke 40 2009 1417 1424
38. N. Sanossian, and B. Ovbiagele Multimodality stroke prevention Neurologist 12 2006 14 31
39. N.F. Gordon, R.D. Salmon, and B.A. Franklin Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia Am J Cardiol 94 2004 1558 1561 (Pubitemid 40268463)
40. N.F. Gordon, C.D. English, and A.S. Contractor Effectiveness of three models for comprehensive cardiovascular disease risk reduction Am J Cardiol 89 2002 1263 1268 (Pubitemid 34606886)